Neurologic Complications of Diabetes

被引：15

作者：

Charnogursky, Gerald A. ^{[1
]}

Emanuele, Nicholas V. ^{[1
]}

Emanuele, Mary Ann ^{[1
]}

机构：

[1] Loyola Univ, Med Ctr, Fahey Ctr, Div Endocrinol & Metab, Maywood, IL 60153 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2014年 / 14卷 / 07期

关键词：

Pathogenesis; Diabetic neuropathy; Painful peripheral neuropathy; Diabetic autonomic neuropathy; Diabetic cardiovascular neuropathy; Diabetic gastroparesis; Therapeutic treatment diabetic neuropathy; ALPHA-LIPOIC ACID; CARDIAC AUTONOMIC NEUROPATHY; HEART-RATE-VARIABILITY; CORNEAL CONFOCAL MICROSCOPY; GLYCATION END-PRODUCTS; DOUBLE-BLIND; PERIPHERAL NEUROPATHY; NATURAL-HISTORY; GLUCOSE CONTROL; RISK-FACTORS;

D O I：

10.1007/s11910-014-0457-5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Neuropathy as a complication of diabetes is common and presents in a wide variety of clinical scenarios. Often the work-up is one of exclusion tempered with monitoring the response of symptoms to treatment options. The collaboration of a neurologist is often crucial to determining the best course of action for the patient. This review will address proposed pathogenic mechanisms and potential therapeutic interventions, both pharmacologic and nonpharmacologic.

引用

页数：16

共 150 条

[1] Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study [J].

Albers, James W. ;

Herman, William H. ;

Pop-Busui, Rodica ;

Feldman, Eva L. ;

Martin, Catherine L. ;

Cleary, Patricia A. ;

Waberski, Barbara H. ;

Lachin, John M. .

DIABETES CARE, 2010, 33 (05) :1090-1096

[2] NONINVASIVE ASSESSMENT OF CARDIAC DIABETIC NEUROPATHY BY C-11 HYDROXYEPHEDRINE AND POSITRON EMISSION TOMOGRAPHY [J].

ALLMAN, KC ;

STEVENS, MJ ;

WIELAND, DM ;

HUTCHINS, GD ;

WOLFE, ER ;

GREENE, DA ;

SCHWAIGER, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1425-1432

[3]

Aminoff M, 1996, NEUROLOGY, V46, P873

[4] THE EFFECT OF INTENSIVE DIABETES THERAPY ON THE DEVELOPMENT AND PROGRESSION OF NEUROPATHY [J].

不详 .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :561-568

[5] Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy [J].

Aronson, D ;

Weinrauch, LA ;

D'Elia, JA ;

Tofler, GH ;

Burger, AJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (04) :449-453

[6] Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration [J].

Aso, Y ;

Fujiwara, Y ;

Inukai, T ;

Takemura, Y .

DIABETES CARE, 1998, 21 (07) :1173-1177

[7] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].

Backonja, M ;

Beydoun, A ;

Edwards, KR ;

Schwartz, SL ;

Fonseca, V ;

Hes, M ;

LaMoreaux, L ;

Garofalo, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836

[8] Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials [J].

Backonja, M ;

Glanzman, RL .

CLINICAL THERAPEUTICS, 2003, 25 (01) :81-104

[9] NGX-4010, a high concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study (vol 7, pg 1106, 2008) [J].

Backonja, M. ;

Wallace, M. S. ;

Blonsky, E. R. .

LANCET NEUROLOGY, 2009, 8 (01) :31-31

[10]

BANNISTER R, 1988, AUTONOMIC FAILURE TX, P569

← 1 2 3 4 5 6 7 8 9 10 →